0001209191-23-042952.txt : 20230720 0001209191-23-042952.hdr.sgml : 20230720 20230720181952 ACCESSION NUMBER: 0001209191-23-042952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230719 FILED AS OF DATE: 20230720 DATE AS OF CHANGE: 20230720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yan Ming CENTRAL INDEX KEY: 0001874041 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40632 FILM NUMBER: 231100711 MAIL ADDRESS: STREET 1: C/O CYTEK BIOSCIENCES, INC. STREET 2: 46107 LANDING PARKWAY CITY: FREMONT STATE: CA ZIP: 94538 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cytek Biosciences, Inc. CENTRAL INDEX KEY: 0001831915 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 472547526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47215 LAKEVIEW BOULEVARD CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: (877) 922-9835 MAIL ADDRESS: STREET 1: 47215 LAKEVIEW BOULEVARD CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: Cytek BioSciences, Inc. DATE OF NAME CHANGE: 20201110 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-19 0 0001831915 Cytek Biosciences, Inc. CTKB 0001874041 Yan Ming C/O CYTEK BIOSCIENCES, INC. 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 1 1 0 0 Chief Technology Officer 1 Common Stock 2023-07-19 4 S 0 20000 8.76 D 7830258 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.65 to $8.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Valerie Barnett, Attorney-in-Fact for Ming Yan 2023-07-20